Quick Takeaways
- MGRX - MANGOCEUTICALS, INC. financial facts are built from SEC company filings data.
- Latest metrics period on this page: Q1 2026.
- Headline metric: Return On Equity -136%.
- Info
- Insider Trading
- Financials
MANGOCEUTICALS, INC. financial metrics
Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q1 2026.
- Symbol
- MGRX on Nasdaq
- Location
- Dallas, TX
- Fiscal year end
- 31 December
- Latest financial report
- 01 Apr 2026
What Changed
- Return On Equity YoY change: <span class="text-green-600">+20%</span>.
- Most recent SEC facts end date: 31 Mar 2026.
Why This Matters
- This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
- Every metric card links to a deeper SEC-backed history page for verification.
Source Evidence
Based on latest 10-Q/10-K
See Original Filing
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.
Latest SEC snapshot (2026-03-31) highlights Return On Equity -136.2%, Return On Assets -73.8%, and Operating Margin -8913.9%.
Compare This Company Through SEC-backed Metrics
Use these links to compare MGRX - MANGOCEUTICALS, INC. against other SEC filers on the same metric, then verify the company history from the paired facts page.
Revenues YoY
Latest value: -26%
NetIncomeLoss YoY
Latest value: -137%
Financial Quality Score
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
31.1/100
Weak Confidence high
Return On Equity
-136%
Metric score 0.0/100
Return On Assets
-74%
Metric score 0.0/100
Financial Health
- Current Ratio
- 0.74x
- Quick Ratio
- 0.6x
- Debt to Equity
- 0.01x
Strengths
Current Ratio, Quick Ratio, and Debt-to-equity
Watchpoints
Return On Equity, Return On Assets, and Operating Margin
Key metrics snapshot
Return On Equity
-136%
YoY: +20%
Industry median: 11% (n=17)
Return On Assets
-74%
YoY: +24%
Industry median: -0.43% (n=17)
Operating Margin
-8914%
YoY: +205%
Current Ratio
0.74x
YoY: +3176%
Industry median: 1.04x (n=17)
Quick Ratio
0.6x
YoY:
Debt-to-equity
0.01x
YoY:
Industry median: 0.42x (n=16)
Revenues YoY
-26%
YoY:
NetIncomeLoss YoY
-137%
YoY:
Industry median: -20% (n=15)
Profitability
| Metric | Latest value | YoY change |
|---|---|---|
| Return On Equity | -136% | +20% |
| Return On Assets | -74% | +24% |
| Operating Margin | -8914% | +205% |
Financial Health
| Metric | Latest value | YoY change |
|---|---|---|
| Current Ratio | 0.74x | +3176% |
| Quick Ratio | 0.6x | |
| Debt-to-equity | 0.01x |
Growth
| Metric | Latest value | YoY change |
|---|---|---|
| Revenues YoY | -26% | |
| NetIncomeLoss YoY | -137% |
Share Metrics
| Metric | Latest value | YoY change |
|---|---|---|
| Entity Common Stock, Shares Outstanding | 16,967,420 | +228% |
How we score
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric | Weight | V1 threshold |
|---|---|---|
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
How Calculated (standard_v1)
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
- TTM Operating Income / TTM Revenues
- Current Assets / Current Liabilities (latest instant quarter)
- (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
- Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
- TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
- TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
- TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
- TTM Revenues YoY
- TTM Net Income YoY